Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia‐inducible factor‐1 alpha
Open Access
- 26 October 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 122 (1) , 5-14
Abstract
Hypoxia‐inducible factor 1 (HIF‐1) plays an essential role in tumor angiogenesis and growth by regulating the transcription of several genes in response to hypoxic stress and changes in growth factors. This study was designed to investigate the effects of deguelin on tumor growth and angiogenesis, and the mechanisms underlying the antitumor activities of deguelin. We show here that orally administered deguelin inhibits tumor growth and blocks tumor angiogenesis in mice. Deguelin decreased expression of HIF‐1α protein and its target genes, such as VEGF, in a subset of cancer cell lines, including H1299 lung cancer cells, and vascular endothelial cells in normoxic and hypoxic conditions. Overexpression of vascular endothelial growth factor by adenoviral vector infection abolished the antiangiogenic effects of deguelin on H1299 nonsmall cell lung cancer cells. Deguelin inhibited de novo synthesis of HIF‐1α protein and reduced the half‐life of the synthesized protein. MG132, a proteasome inhibitor, protected the hypoxia‐ or IGF‐induced HIF‐1α protein from deguelin‐mediated degradation. Our findings suggest that deguelin is a promising antiangiogenic therapeutic agent in cancer targeting HIF‐1α. Considering that HIF‐1α is overexpressed in a majority of human cancers, deguelin could offer a potent therapeutic agent for cancer.Keywords
This publication has 44 references indexed in Scilit:
- Tumor hypoxia and cancer progressionCancer Letters, 2006
- Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in miceBlood, 2006
- Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell CarcinomaMolecular and Cellular Biology, 2005
- Identification of Novel Small Molecule Inhibitors of Hypoxia-Inducible Factor-1 That Differentially Block Hypoxia-Inducible Factor-1 Activity and Hypoxia-Inducible Factor-1α Induction in Response to Hypoxic Stress and Growth FactorsCancer Research, 2005
- Interaction of the PAS B Domain with HSP90 Accelerates Hypoxia-Inducible Factor-1α StabilizationCellular Physiology and Biochemistry, 2004
- Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functionsExperimental & Molecular Medicine, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrestEuropean Journal of Cancer, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002